Henry Schein, Inc. $HSIC Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 953,792 shares of the company’s stock after selling 7,369 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Henry Schein were worth $69,912,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock worth $436,489,000 after buying an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock valued at $153,480,000 after acquiring an additional 103,384 shares during the period. Burgundy Asset Management Ltd. raised its position in Henry Schein by 33.9% in the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock valued at $153,105,000 after purchasing an additional 566,530 shares during the last quarter. Clarkston Capital Partners LLC boosted its stake in Henry Schein by 0.4% during the 1st quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock worth $119,965,000 after purchasing an additional 7,345 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Henry Schein by 1.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock worth $82,440,000 after purchasing an additional 11,999 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HSIC has been the topic of a number of recent research reports. Weiss Ratings restated a “hold (c)” rating on shares of Henry Schein in a research note on Wednesday, October 8th. Stifel Nicolaus reiterated a “hold” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Robert W. Baird reaffirmed a “neutral” rating and set a $72.00 price objective (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Leerink Partners set a $75.00 target price on Henry Schein in a research note on Monday, July 14th. Finally, Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Five investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $76.67.

Henry Schein Stock Up 0.5%

Shares of Henry Schein stock opened at $64.23 on Wednesday. The business’s 50 day simple moving average is $67.01 and its 200-day simple moving average is $68.56. The stock has a market capitalization of $7.79 billion, a price-to-earnings ratio of 20.72, a PEG ratio of 2.11 and a beta of 0.81. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the firm earned $1.23 EPS. Henry Schein’s revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.